CA-NTT
NTT Ltd., a leading IT infrastructure and services company, today announced a strategic engagement with Qualcomm Technologies, Inc., a global leader in semiconductor technologies, to invest in and accelerate the development of the 5G device ecosystem to facilitate private 5G adoption, which is critical to powering AI at the edge.
As part of a multi-year engagement, NTT and Qualcomm Technologies will prioritize the development of 5G enabled devices to accelerate innovation with global enterprise customers, a critical catalyst in driving widespread enterprise adoption of private 5G, a market which IDC estimates will exceed $8 Billion by 2026. Qualcomm Technologies’ leadership in application specific semiconductors and 5G chipsets, combined with NTT’s leadership in private 5G, will strengthen the 5G ecosystem, advance AI processing capabilities at the edge and spur innovation across industries.
Driving the 5G device ecosystem
With enterprises accelerating digitization efforts, more connectivity and even more devices are needed. NTT and Qualcomm Technologies will use their combined expertise to meet the need for 5G-enabled devices that support use cases, such as push-to-talk devices, augmented reality headsets, computer vision cameras and sensors at the edge across the manufacturing, automotive, logistics and other industries.
“This collaboration is truly an exciting one because we are answering the demand we’re hearing from our clients. Together with Qualcomm Technologies, we will strengthen the 5G ecosystem delivering the devices our customers require in a simple and cost-effective way, empowering them as they continue along their digital transformation journey,” said Shahid Ahmed, Executive Vice President, New Ventures & Innovation at NTT Ltd. “By working with Qualcomm Technologies, we will further accelerate demand for private 5G across global industries.”
“The proliferation of 5G-enabled devices is a critical component of shaping a more digital and sustainable future. It forms the backbone of many tech advancements that can improve efficiency and sustainability through efficient resource management, energy conservation, and are pivotal for innovation across various industries,” said Mark Bidinger, President, Commercial & Industrial Segments & Channels at Schneider Electric. “NTT’s collaboration with Qualcomm represents a significant step forward in advancing private 5G adoption and meeting the unique demands of the Internet of Things and Machine Learning.”
Accelerating AI adoption at the edge
For AI to scale and make an impact on enterprise operations and organizations’ bottom line, AI processing needs to happen in a hybrid form—both in the cloud and at the edge of the network. The silicon that Qualcomm Technologies develops includes built-in AI and machine learning models, making it well-positioned for growing AI capabilities at the edge. Qualcomm Technologies’ experience with scaling AI technology allows the company to touch a wide range of devices and applications including smartphones, laptops, sensors, automotive solutions, and networking.
“Qualcomm Technologies’ 5G chipsets are prepared for the widespread adoption of AI applications at the edge and, together with NTT, we’ll enhance innovative change across the 5G device ecosystem.” said Jeffery Torrance, Senior Vice President & General Manager, Connected Smart Systems, Qualcomm Technologies, Inc. “NTT is the voice of the customer and combined with Qualcomm Technologies’ semiconductor expertise, we can enable OEMs to build the devices that will benefit a wide range of use cases and customers.”
Qualcomm Technologies and NTT will work together to deliver 5G-ready devices with Qualcomm Technologies’ 5G chipsets with AI models built in to enhance AI at the edge through various applications, such as image recognition, with capabilities ranging from counting items and identifying object characteristics to verifying workers wearing safety masks or hardhats (PPE). Deploying AI applications through NTT’s Edge as a Service will assist enterprises with workplace safety, optimization, and security.
Device as a service
As part of NTT’s end-to-end Edge as a Service offering, NTT is now offering manages services for Device as a Service to make it easy for customers to access, upgrade, and recycle 5G and edge devices and simplify device lifecycle management as well as reduce IT maintenance and costs. The cost-effective per-user, per-month fee model means enterprises no longer need to make large capital investments upfront, but rather consume on a more comfortable monthly fee basis, making it easier for customers to deploy edge devices at scale.
###
About NTT Ltd.
As part of NTT DATA, a USD 30 billion IT services provider, NTT Ltd. is a leading IT infrastructure and services company serving 65% of the Fortune Global 500 and more than 75% of the Fortune Global 100. We lay the foundation for organizations’ edge-to-cloud networking ecosystem, simplify the complexity of their workloads across multicloud environments, and innovate at the edge of their IT environments where networks, cloud and applications converge. We offer tailored infrastructure and ensure consistent best practices in design and operations across all of our secure, scalable and customizable data centers. On the journey towards a software-defined future, we support organizations with our platform-delivered infrastructure services. We enable a connected future.
Visit us at services.global.ntt.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230926998616/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom